Izabela Chmielewska

10PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 03, 2026
When genetics meets immunology: the assessment of genetic and immunological backgrounds in advanced NSCLC patients treated with immunotherapy - preliminary study.

Natalia Krzyżanowska, Marcin Nicoś, Kamila Wojas-Krawczyk

|May 28, 2025
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer.

Ferdinandos Skoulidis, Bob T Li, Adrianus Johannes de Langen

|Nov 07, 2024
Exploring immunotherapy efficacy in non-small cell lung cancer patients with BRAF mutations: a case series and literature review.

Izabela Chmielewska, Paweł Krawczyk, Magdalena Wójcik-Superczyńska

|Jul 29, 2023
Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations-A Comprehensive Review and Description of Single Site Experience.

Izabela Chmielewska, Paweł Krawczyk, Anna Grenda

|Mar 11, 2023
Treatment Patterns, Testing Practices, and Outcomes in Patients with EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer in Poland: A Descriptive Analysis of National, Multicenter, Real-World Data from the REFLECT Study.

Adam Pluzanski, Maciej Bryl, Izabela Chmielewska

|Dec 23, 2022
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.

Anna Grenda, Ewelina Iwan, Paweł Krawczyk

Pageof 2

Frequent Collaborators

3 joint publications

Janusz Milanowski

3 joint publications

Michał Gil

2 joint publications

Tomasz Jankowski

2 joint publications

Paweł Krawczyk